NDC 0904-6949
Levothyroxine Sodium 0.025 mg tablet
On the label: Major Pharmaceuticals. It's repackaged: Major Pharmaceuticals rebottles it from Lupin Pharmaceuticals, Inc.'s NDC 68180-965.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Dhar, India | Makes it and packages it | Problems found, fixed voluntarilySep 27, 2024 · 4 inspections |
Recalls
- Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot#: N02212, Exp. Date 07/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot #: N02200, Exp. Date 10/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot #: N02310, Exp. Date 01/2027 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot #: N02203, Exp. Date 09/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot #: N02266, Exp. Date 11/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Lot #: N02167, Exp. Date 07/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Bag lot #: N02212A, N02212B, Exp. Date 07/2026; Blister lot #: N02212, Exp. Date 07/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Bag lot #: N02200A, N02200B, Exp. Date 10/2026; Blister lot #: N02200, Exp. Date 10/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Bag lot #: N02172A, N02172B, Exp. Date 07/2026; N02288A, N02288B, Exp. Date 12/2026; Blister lot #: N02172, Exp. Date 07/2026; N02288, Exp. Date 12/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Bag lot #: N02266A, N02266B, Exp. Date 11/2026; Blister lot #: N02266, Exp. Date 11/2026 - Jul 13, 2026 · Class II · Major Pharmaceuticals
Subpotent Drug
Lots: Bag lot #: N02167A, Exp. Date 07/2026; Blister lot # N02167, Exp. Date 07/2026 - Dec 20, 2024 · Class II · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
Lots: Lot# LA01276, Exp Date: 07/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet, oral
- Strength
- 0.025 mg
- Approval
- ANDA ANDA209713
- On the market since
- Mar 20, 2019
- Package NDCs
0904-6949-61- Official label
- DailyMed (National Library of Medicine), updated Jun 19, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?